Global Nuclear Medicine/Radiopharmaceuticals Market, 2022 -

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 27, 2016 at 7:15 AM

Global Nuclear Medicine/Radiopharmaceuticals Market, 2022 - Market is expected to reach $9,275.3

Dublin, July 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022" report to their offering. The global nuclear medicine/radiopharmaceutical market is expected to reach $9,275.3 million by 2022

Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy. Non-invasive nuclear medicine imaging technique provides functional information at both molecular and cellular level and helps measuring the uptake and turnover of target-specific radiotracers in tissue. Radioisotopes are used in a wide variety of applications like oncology, cardiovascular and neurological disorders. But in recent times, advancements in the field of nuclear medicine and radioactive tracers have emerged to provide few practical methods for studying the limited metabolic activities of bones and teeth, hence has found a role in dental science research. Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.

The nuclear medicine market end-users include medical, academic research laboratories and industries. The end-users by medical further segmented into hospitals and diagnostic centers. The factors driving the growth of this market are increased application of radiopharmaceuticals, rise in public awareness, usage of hybrid imaging, abundance of radio pharmaceuticals, technological advancements; alpha radio immunotherapy based targeted cancer treatment and wide range of available products likely to propel the nuclear medicine market. In addition to this, increasing need in emerging markets, production of radio pharmaceuticals from cyclotrons, efficient diagnosis and treatments, emerging radio isotopes, increasing therapeutic application areas and replacement of old/traditional equipment are some of the opportunities that are propelling the growth of the market. However, regulatory issues, high cost and supply shortage of isotopes, shorter half life of radiopharmaceuticals, and threat from traditional/alternative diagnostic procedures are hampering the growth of the market. The threats for the nuclear medicine/radiopharmaceuticals market include huge capital investment and shortage of qualified technicians. The major problem area of nuclear medicine market is closure of reactors. Key Topics Covered: 1 Executive Summary 2 Introduction 2.1 Key Take Aways 2.2 Report Description 2.3 Markets Covered 2.4 Stakeholders 2.5 Research Methodology 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.4 Problem Areas 3.5 Winning Imperatives 3.6 Regulatory Guidelines 3.7 Reimbursement Scenario & Challenges 3.8 Patent Trends 3.9 Supply Chain Analysis 3.10 List Of Potential New Reactors 3.11 Porter's Five Force Analysis 3.12 Market Share Analysis By Major Players 4 Radiopharmaceuticals By Type 4.1 Introduction 4.2 Diagnostics 4.3 Therapeutics 5 Global Nuclear Medicine Market By End-Users 5.1 Introduction 5.2 Medical 5.3 Academic Research Laboratories 5.4 Industries 6 Stable Isotopes 6.1 Introduction 6.2 Market Analysis 6.3 Stable Isotopes Market, By Isotopes 6.4 Stable Isotopes Market, By Applications 6.5 Stable Isotopes Market, By Geography 7 Regional Analysis 7.1 Introduction 7.2 North America 7.3 Europe 7.4 Asia-Pacific 7.5 Rest Of The World 8 Competitive Landscape 8.1 Introduction 8.2 New Product Launches 8.3 Agreements, Partnership, Collaboration & Joint Ventures 8.4 Approvals 8.5 Expansions 8.6 Mergers & Acquisitions 8.7 Other Developments 9 Major Player Profiles 9.1 Bayer Healthcare 9.2 Cardinal Health Inc. 9.3 Cambridge Isotope Laboratories Inc. 9.4 Ge Healthcare 9.5 Iba Group 9.6 Isotec Inc 9.7 Lantheus Medical Imaging Inc. 9.8 Mallinckrodt Plc 9.9 Nordion Inc 9.10 Ntp Radioisotopes Soc Ltd 9.11 Siemens Healthcare 9.12 Taiyo Nippon Sanso Corporation Companies Mentioned - Ablynx Nv - Abx Gmbh - Actinium Pharmaceuticals, Inc - Advanced Accelerator Applications - Advanced Medical Isotope Corporation - Affibody Ab - Algeta Asa - Aptuit - Areva Med - Arronax - Auspex Pharmaceuticals - Bard Medicals - Bavarian Nordic - Bayer Healthcare - Best Medical International, Inc - Bio Analytical Research Corporation Laboratories - Bio-Nucleonics,Inc - Bracco Diagnostics Incs - Btg International Ltd - Bv Cyclotron Vu - Cambridge Isotope Laboratories Inc. - Cardinal Health Inc. - Cellectar Biosciences - Centre For Probe Development And Commercialization - China Isotope Corporation - Clarity'S Pharmaceuticals - Coqui Pharmaceuticals - Cortecnet - Cp Medical - Digirad Corporation - Draximage Inc. - Eckert & Ziegler Strahlen - Eden Radioisotopes Llc - Eli Lilly & Co - Eurisotop - Fujifilm Corporation - Ge Healthcare - Huayi Isotopes Co - Iba Group - Ibt-Bebig - Idb Holland Bv - Immunomedics - Industrial Nuclear Company - International Isotopes Inc. - Invap S.E - Iso Ray Medical Inc - Iso Therapeutics Group, Llc - Iso-Analytical Ltd - Isoaid Llc - Isoflex Isotope - Isorad Ltd - Isotec Inc - Isotope Technologies Garching - Ithemba Labs - Joint Stock Company Isotope - Lantheus Medical Imaging Inc - Linde Group - Mallinckrodt Plc - Medi-Physics, Inc - Medical Isotopes, Inc - Mediso Medical Imaging Systems - Memorial Sloan Kettering Cancer Center - Navidea Biopharmaceuticals Inc - Nihon Medi Physics Co Ltd - Nordion Inc. - Northstar Medical Technologies - Ntp Radioisotopes Soc Ltd - Octreopharm Sciences Gmbh - Ostuka Pharmaceuticals Co Ltd - Pars Isotope - Peregrine Pharmaceuticals, Inc - Perkin Elmer - Perma-Fix Medical Sa - Petnet Solution - Philips Health Care - Positron Corporation - Radiomedix, Inc. - Rotem Medical - Royal Philips Electronics - Sanofi - Sercon Australia Pvt Ltd - Sercon Ltd - Shangai Research Institute Of Chemical Industry - Shine Medical Technologies, Inc - Siemens Healthcare - Sievert - Sirtex - Source Production And Equipment Company+F191 - Spectrum Pharmaceuticals, Inc - Spepharm Ag - Stb Isotope Germany Gmbh - Sterigenics International - Steripet - Tayyo Nippon Sanso Corporation - Theragenics Corporation - Thermo Fisher Scientific - Toshiba Medical Systems Corporation - Tracerco - Trigon Biotechnology Inc - Urenco - Westinghouse Electric Company - Zevacor Molecular For more information visit http://www.researchandmarkets.com/research/4bb55b/nuclear

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Nuclear Medicine and Radiopharmacology

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Phoenix Scholar Examines AI and Institutional Trust

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Amap, Sands China Unleash Tutu Robots for Resort Duty

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

Young Visionaries Win Junior Medals at STARMUS VIII

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

CenterPoint Deploys Crews for Hurricane Aid Relief

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...

Arrvel's Thermal Printers: Aiming at E-Com Sellers

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...